June 8 (Reuters) - Eli Lilly (LLY.N), opens new tab shares rose 4% on Monday, driven by compelling new data for its next-generation obesity drug, retatrutide, with analysts and investors expecting it ...
Why Is Morningstar So Bearish on SpaceX’s IPO? We value SpaceX SPCX at $63 per share, a 53% discount to the upcoming IPO’s offering price. Our valuation is the result of mathematics more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results